Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer diagnostics
MedTech
ASCO: HER2 diagnostics need a revolution after Enhertu data
“Pathologists have a hard time distinguishing between” IHC 0 and IHC 1+ HER2 expression on existing assays, said MD Anderson's Debu Tripathy.
Angus Liu
Jun 6, 2022 11:11am
Paige nets European OK for AI to spot prostate cancer biomarkers
May 12, 2022 3:06pm
Illumina outlines future long-read chemistry, posts sales record
Jan 10, 2022 6:13pm
AI developer Paige scores CE marks in breast, prostate cancers
Dec 14, 2020 7:26am
Breast cancer study uncovers new RNA targets for treatment
Oct 19, 2020 8:55am
Imperial, University of Leicester tap Natera for breast cancer study
Nov 1, 2017 11:55am
